An observational study in Chronic Pain, sponsored by University of Aberdeen. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-28.
Sponsored by University of Aberdeen · Observational
Investigators will explore healthcare professionals and patients' experience in chronic pain management within primary care. Investigators will use this information to develop a decision aid tool tool which patients with chronic pain could use to help them make an informed decision during a consultation with their healthcare professionals.
2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.
This study's enrollment of 50 is below the median of 126 across 688 observational studies indexed under Chronic Pain.
Browse Chronic Pain studies →University of Aberdeen is the lead sponsor of 170 studies on the registry; 23 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who are dealing with non-malignant chronic pain.
Exclusion Criteria:
No intervention - conduct a qualitative interview with patients regarding their experience.
UPP Decision Aid Tool
Semi-structured interviews with patients with chronic pain and healthcare professionals (General Practitioner and Pharmacists) perspectives on chronic pain management in NHS Grampain. Data will be used to support the design of a decision aid tool and the development of study information material and standard operating procedures of a subsequent feasibility study aimed at testing the tool.
Time frame: Day 1
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Aberdeen